Immupharma PLC Grant of Options (6023K)

TIDMIMM

RNS Number : 6023K

Immupharma PLC

22 December 2022

22 December 2022

ImmuPharma PLC

("ImmuPharma" or the "Company")

Grant of Share Options

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces the grant of share options as follows.

The Remuneration Committee (comprising the Non Executive Directors) has determined to award Share Options to the Executive Directors with exercise prices and conditions which reflect the underlying objective of restoring and enhancing shareholder value as follows:

   Tim McCarthy                    1,800,000 share options (exercise price GBP0.05) 
   Tim McCarthy                    1,800,000 share options (exercise price GBP0.11) 
   Tim Franklin                       1,575,000 share options (exercise price GBP0.05) 
   Tim Franklin                       1,575,000 share options (exercice price GBP0.11) 

Vesting & Performance conditions:

   --    3 year vesting period; and 
   --    1st patient dosed in the next P140 (Lupuzor(TM)) clinical trial. 

ENDS

 
 
   For further information please contact: 
    ImmuPharma PLC ( www.immupharma.com )          [phone] 
     Tim McCarthy, Chief Executive Officer 
     Lisa Baderoon, Head of Investor Relations      + 44 (0) 7721 413496 
 
 
     SPARK Advisory Partners Limited (NOMAD) 
     Neil Baldwin                                   [phone] 
 
     Stanford Capital Partners (Joint Broker) 
     Patrick Claridge, John Howes, Bob Pountney     [phone] 
 
     SI Capital (Joint Broker) 
     Nick Emerson                                   [phone] 
 

Notes to Editors

About ImmuPharma PLC

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, Lupuzor(TM), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

For additional information about ImmuPharma please visit www.immupharma .co.uk

ImmuPharma's LEI (Legal Entity Identifier) code : 213800VZKGHXC7VUS895.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
  1    Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                               Tim McCarthy 
      ---------------------------------  -------------------------------------------- 
  2    Reason for the notification 
      ------------------------------------------------------------------------------- 
 a)    Position / status                  Chairman and Chief Executive Officer 
      ---------------------------------  -------------------------------------------- 
 b)    Initial notification               Initial notification 
        / Amendment 
      ---------------------------------  -------------------------------------------- 
  3    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------- 
 a)    Name                               ImmuPharma PLC 
      ---------------------------------  -------------------------------------------- 
 b)    LEI                                213800VZKGHXC7VUS895 
      ---------------------------------  -------------------------------------------- 
  4    Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      ------------------------------------------------------------------------------- 
 a)    Description of the                 Ordinary Shares of 1p each 
        financial instrument 
        , type of instrument 
                                           ISIN: GB0033711010 
        Identification code 
      ---------------------------------  -------------------------------------------- 
 b)    Nature of the transaction          Grant of share options over new Ordinary 
                                           Shares 
      ---------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s)                  Exercise Price             Volume 
      ---------------------------------  --------------------------  ---------------- 
   5 pence                                                               1,800,000 
  -----------------------------------------------------------------  ---------------- 
   11 pence                                                              1,800,000 
  -----------------------------------------------------------------  ---------------- 
 d)    Aggregated information             N/A 
 
        - Aggregated volume 
 
        - Price 
      ---------------------------------  -------------------------------------------- 
 e)    Date of the transaction            22 December 2022 
      ---------------------------------  -------------------------------------------- 
 f)    Place of the transaction           n/a 
      ---------------------------------  -------------------------------------------- 
 
 
  1    Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                               Tim Franklin 
      ---------------------------------  -------------------------------------------- 
  2    Reason for the notification 
      ------------------------------------------------------------------------------- 
 a)    Position / status                  Chief Operating Officer 
      ---------------------------------  -------------------------------------------- 
 b)    Initial notification               Initial notification 
        / Amendment 
      ---------------------------------  -------------------------------------------- 
  3    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------- 
 a)    Name                               ImmuPharma PLC 
      ---------------------------------  -------------------------------------------- 
 b)    LEI                                213800VZKGHXC7VUS895 
      ---------------------------------  -------------------------------------------- 
  4    Details of the transaction(s): section to be repeated for 
        (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions have 
        been conducted 
      ------------------------------------------------------------------------------- 
 a)    Description of the                 Ordinary Shares of 1p each 
        financial instrument 
        , type of instrument 
                                           ISIN: GB0033711010 
        Identification code 
      ---------------------------------  -------------------------------------------- 
 b)    Nature of the transaction          Grant of share options over new Ordinary 
                                           Shares 
      ---------------------------------  -------------------------------------------- 
 c)    Price(s) and volume(s)                  Exercise Price             Volume 
      ---------------------------------  --------------------------  ---------------- 
   5 pence                                                               1,575,000 
  -----------------------------------------------------------------  ---------------- 
   11 pence                                                              1,575,000 
  -----------------------------------------------------------------  ---------------- 
 d)    Aggregated information             N/A 
 
        - Aggregated volume 
 
        - Price 
      ---------------------------------  -------------------------------------------- 
 e)    Date of the transaction            22 December 2022 
      ---------------------------------  -------------------------------------------- 
 f)    Place of the transaction           n/a 
      ---------------------------------  -------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUUOBRUBUUURA

(END) Dow Jones Newswires

December 22, 2022 02:55 ET (07:55 GMT)